GLONGHUI, Oct. 9 | According to Reuters, Pfizer and its German partner BioNTech won a lawsuit invalidating two of competitor CureVac's patents in the London High Court on Tuesday. Pfizer and BioNTech filed a lawsuit in September 2022 over a patent for mRNA technology, which is the foundation of Pfizer and BioNTech's COVID-19 vaccine. Notably, Tuesday's ruling only targets the London “Global Legal War” lawsuit initiated by Pfizer, BioNTech, and CureVac, and the three parties also involved lawsuits in the US and Germany.
辉瑞和BioNTech在英国赢得mRNA疫苗专利诉讼
Pfizer and BioNTech win mRNA vaccine patent litigation in the United Kingdom.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.